IP Library Granted Patent US 11,135,179
Granted Patent B1
US 11,135,179 · App. 16/282,006 · Granted Oct 5, 2021

Eye health supplement

Inventor: James Stringham (Durham, NC)
Assignee: QH Holdings (Oregon), Inc.
A61K31/065A61K31/202A61K31/341A61K31/355A61K33/30A61K35/60A61K35/644A61K36/28A61K36/48A61K47/42A61P27/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,135,179
App. No.
16/282,006
Granted
Oct 5, 2021
Kind
B1
Abstract

An eye health supplement and methods of using the eye health supplement are disclosed.

Claims (43)

1. An eye health supplement dosage form, comprising:

4-6 mg zeaxanthin;

15-30 mg lutein;

62.5-250 mg vitamin C;

42-168 mg vitamin E;

3.75-15 mg zinc;

carob; and

75-300 mg omega-3 oils providing 37.5-150 mg docosahexaenoic acid (DHA) and 37.5-150 mg eicosapentaenoic acid (EPA),

wherein the zinc is provided by zinc gluconate.

2. The eye health supplement dosage form of claim 1 , wherein the eye health supplement dosage form does not comprise resveratrol.

3. The eye health supplement dosage form of claim 1 , comprising:

1 part by weight zeaxanthin;

5 parts by weight lutein;

41.7 parts by weight vitamin C;

28 parts by weight vitamin E;

2.5 parts by weight zinc; and

50 parts by weight omega-3 oils providing 25 parts by weight DHA and 25 parts by weight EPA.

4. The eye health supplement dosage form of claim 1 , further comprising fish oil, gelatin, glycerin, sunflower oil, yellow beeswax, water, carob, or any combination thereof.

5. The eye health supplement dosage form of claim 4 , consisting essentially of zeaxanthin, lutein, vitamin C, vitamin E, zinc, DHA, EPA, fish oil, gelatin, glycerin, sunflower oil, yellow beeswax, water, and carob.

6. The eye health supplement dosage form of claim 1 , consisting essentially of:

at least 6 mg zeaxanthin;

at least 30 mg lutein;

125 mg vitamin C;

84 mg vitamin E;

7.5 mg zinc;

75 mg DHA;

75 mg EPA;

fish oil;

gelatin;

glycerin;

sunflower oil;

yellow beeswax;

water; and

carob.

7. The eye health supplement dosage form of claim 1 , wherein the lutein is present as free lutein.

8. The eye health supplement dosage form of claim 1 , wherein the dosage form is a softgel.

9. A method of supporting eye health, comprising administering to a subject a dose of an eye health supplement dosage form according to claim 1 , wherein the dose is effective to support eye health.

10. The method of claim 9 , wherein administering is performed daily.

11. The method of claim 9 , wherein the dose comprises 250 mg vitamin C, 168 mg vitamin E, 15 mg zinc, 30 mg lutein, 6 mg zeaxanthin, 150 mg DHA, and 150 mg EPA.

12. The method of claim 11 , wherein the amounts are substantially equal to 250 mg vitamin C, 168 mg vitamin E, 15 mg zinc, 30 mg lutein, 6 mg zeaxanthin, 150 mg DHA, and 150 mg EPA.

13. The method of claim 9 , wherein administering comprises orally administering two eye health supplement dosage forms to the subject, each eye health supplement dosage form comprising 3 mg zeaxanthin, 15 mg lutein, 125 mg vitamin C, 84 mg vitamin E, 7.5 mg zinc, 75 mg DHA, and 75 mg EPA.

14. The method of claim 13 , wherein the amounts are substantially equal to 3 mg zeaxanthin, 15 mg lutein, 125 mg vitamin C, 84 mg vitamin E, 7.5 mg zinc, 75 mg DHA, and 75 mg EPA.

15. The method of claim 9 , wherein supporting eye health comprises supporting a healthy macula, supporting visual performance; or a combination thereof.

Assignments (2)
MERGER Recorded Oct 28, 2019
From: QUANTUM, INC.
To: QH HOLDINGS (OREGON), INC.
Reel/Frame 050844/0484 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2019
From: STRINGHAM, JAMES
To: QUANTUM, INC.
Reel/Frame 048984/0021 →
Continuity (1)
Provisional Application 62786266 · Dec 28, 2018